![](/img/cover-not-exists.png)
P-530 Topoisomerase inhibitors: Combination of innotecan and epirubicin is feasible as salvage therapy for heavily pre-treated advanced lung cancer patients
Malik, S., Min, F., Hwang, J., Marshall, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81023-2
Date:
July, 2005
File:
PDF, 287 KB
english, 2005